KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Jazz Pharmaceuticals (JAZZ) Return on Equity: 2009-2025

Historic Return on Equity for Jazz Pharmaceuticals (JAZZ) over the last 13 years, with Sep 2025 value amounting to 0.15%.

  • Jazz Pharmaceuticals' Return on Equity rose 3.00% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year increase of 3.00%. This contributed to the annual value of 0.14% for FY2024, which is 2.00% up from last year.
  • As of Q3 2025, Jazz Pharmaceuticals' Return on Equity stood at 0.15%, which was up 20.45% from 0.12% recorded in Q2 2025.
  • Jazz Pharmaceuticals' Return on Equity's 5-year high stood at 0.15% during Q3 2025, with a 5-year trough of -0.12% in Q1 2022.
  • For the 3-year period, Jazz Pharmaceuticals' Return on Equity averaged around 0.08%, with its median value being 0.11% (2023).
  • Per our database at Business Quant, Jazz Pharmaceuticals' Return on Equity decreased by 26bps in 2022 and then grew by 19bps in 2023.
  • Quarterly analysis of 5 years shows Jazz Pharmaceuticals' Return on Equity stood at -0.08% in 2021, then rose by 1bps to -0.07% in 2022, then climbed by 19bps to 0.12% in 2023, then rose by 2bps to 0.14% in 2024, then climbed by 3bps to 0.15% in 2025.
  • Its Return on Equity stands at 0.15% for Q3 2025, versus 0.12% for Q2 2025 and 0.14% for Q4 2024.